Literature DB >> 25683905

Moyamoya: defining current knowledge gaps.

Vijeya Ganesan1, Edward R Smith2.   

Abstract

Mesh：

Year:  2015        PMID： 25683905     DOI： 10.1111/dmcn.12708

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN： 0012-1622            Impact factor:   5.449


× No keyword cloud information.
  6 in total

1.  Clinical outcomes after revascularization for pediatric moyamoya disease and syndrome: A single-center series.

Authors:  Ramin A Morshed; Adib A Abla; Daniel Murph; Jasmin M Dao; Ethan A Winkler; Jan-Karl Burkhardt; Kathleen Colao; Steven W Hetts; Heather J Fullerton; Michael T Lawton; Nalin Gupta; Christine K Fox
Journal:  J Clin Neurosci       Date:  2020-08-19       Impact factor: 1.961

2.  Preliminary application of CT perfusion source images for evaluating regional collateral circulation in unilateral Moyamoya disease.

Authors:  Jing Xue; Yujing Peng; Yanan Zhang; Weiqi Chen; Yuesong Pan; Yu Qi; Lina Hao; Weibin Gu; Ning Wang; Peiyi Gao
Journal:  Quant Imaging Med Surg       Date:  2019-04

Review 3.  Juvenile Moyamoya and Craniosynostosis in a Child with Deletion 1p32p31: Expanding the Clinical Spectrum of 1p32p31 Deletion Syndrome and a Review of the Literature.

Authors:  Paolo Prontera; Daniela Rogaia; Amedea Mencarelli; Valentina Ottaviani; Ester Sallicandro; Giorgio Guercini; Susanna Esposito; Anna Bersano; Giuseppe Merla; Gabriela Stangoni
Journal:  Int J Mol Sci       Date:  2017-09-17       Impact factor: 5.923

4.  Predictors of clinical or cerebral lesion progression in adult moyamoya angiopathy.

Authors:  Dominique Hervé; Nathanaelle Ibos-Augé; Lionel Calvière; Christina Rogan; Marc Antoine Labeyrie; Jean Pierre Guichard; Ophélia Godin; Manoelle Kossorotoff; Marie Odile Habert; Elisabeth Tournier Lasserve; Sylvie Chevret; Hugues Chabriat
Journal:  Neurology       Date:  2019-06-25       Impact factor: 9.910

5.  Non-invasive Urinary Biomarkers in Moyamoya Disease.

Authors:  Julie Sesen; Jessica Driscoll; Alexander Moses-Gardner; Darren B Orbach; David Zurakowski; Edward R Smith
Journal:  Front Neurol       Date:  2021-04-01       Impact factor: 4.003

6.  PHACTR1 is associated with disease progression in Chinese Moyamoya disease.

Authors:  Yongbo Yang; Jian Wang; Qun Liang; Yi Wang; Xinhua Chen; Qingrong Zhang; Shijie Na; Yi Liu; Ting Yan; Chunhua Hang; Yichao Zhu
Journal:  PeerJ       Date:  2020-05-05       Impact factor: 2.984
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.